Literature DB >> 2496139

Utilization of GnRH agonists for poor responders in an IVF programme.

J Belaisch-Allart1, J Testart, R Frydman.   

Abstract

Thirty-four patients in whom conventional ovarian stimulation had previously failed twice due to low levels of oestradiol, received ovarian stimulation by pure FSH for 5 days, followed by a combination of FSH and HMG, after a preliminary period of pituitary de-sensitization with LHRH agonist. Oocytes were recovered from 33 patients and 28 embryos replaced, 10 became pregnant and eight pregnancies were ongoing and resulted in the birth of 13 healthy babies. This ongoing pregnancy rate of 23.5% per treatment cycle is identical to that reported for normally responding patients. The use of LHRH agonists in so-called poor responders is of obvious interest.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496139     DOI: 10.1093/oxfordjournals.humrep.a136840

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  "Poor responders": screening and treatment possibilities.

Authors:  F Olivennes; R Fanchin; D De Ziegler; R Frydman
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

2.  Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.

Authors:  A B van de-Helder; F M Helmerhorst; A Blankhart; R Brand; C Waegemaekers; N Naaktgeboren
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

3.  Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.

Authors:  J M Cummins; J M Yovich; W R Edirisinghe; J L Yovich
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-12

4.  The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment.

Authors:  J Dor; D S Seidman; I Ben-Shlomo; D Levran; A Karasik; S Mashiach
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

Review 5.  Clinical uses of gonadotropin-releasing hormone analogues.

Authors:  R F Casper
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

6.  Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG.

Authors:  Z Ben-Rafael; D Bider; U Dan; M Zolti; D Levran; S Mashiach
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.